Magplasma, Inc.
Brighton, MI
- UEI
- SAAWDN44L2K1
- CAGE
- 83NP1
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 541611 Administrative Management and General Management Consulting Services
- 541618 Other Management Consulting Services
- 541690 Other Scientific and Technical Consulting Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- SAM.gov registration date
- Physical address
- 81 Summit St, Brighton, MI 48116, USA
- Website
- magplasma.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Materials
- Chemicals
- Commodity Chemicals
- SIC code
- 73 Business Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $54,998 |
| FY2024 | $342,217 |
Contract awards
Similar vendors
About the company
Magplasma, Inc. is a veteran-owned, service-disabled veteran-owned small business that specializes in developing innovative plasma-based technologies for infectious disease protection and sterilization. Registered in SAM.gov since May 2018 and operating as a for-profit corporate entity, the company focuses on advanced technological solutions for contamination control and public health safety. The organization has demonstrated expertise in creating cutting-edge technologies that address critical challenges in infectious disease prevention and sterilization across various sectors.
Over the past three years, Magplasma, Inc. has secured multiple federal contracts primarily with civilian agencies, with a substantial focus on vehicle infectious diseases protection and cold plasma sterilization technologies. The Department of Homeland Security's Science and Technology Directorate and Countering Weapons of Mass Destruction division have been significant contract sources, awarding the company multiple Small Business Innovation Research (SBIR) contracts. These contracts, ranging from $148,252 to $997,234.94, have been predominantly set aside for small businesses and involve definitive contract types. The company's most recent contracts include a September 2024 DHS SBIR Phase II contract for vehicle infectious diseases protection and an August 2024 NASA SBIR Phase I contract for cold plasma sterilization, demonstrating their ongoing commitment to developing innovative technologies that enhance public health and safety through advanced plasma-based solutions.
SBA capabilities narrative
MagPlasma develops and sells plasma systems for material processing, chemical manufacture, equipment disinfection, and air purification.
Quick answers
Is Magplasma, Inc. registered in SAM.gov?
Yes. Magplasma, Inc.'s SAM.gov registration is active through July 20, 2027.
How much has Magplasma, Inc. received in federal contracts?
Federal contracts obligated $54,998 to Magplasma, Inc. in fiscal year 2025 and $397,215 in fiscal years 2023 through 2027.
How does Magplasma, Inc. rank among federal contractors?
Magplasma, Inc. ranked #36 in PSC AJ15 in FY2025.
What is Magplasma, Inc.'s most recent federal award?
Magplasma, Inc.'s most recent federal contract award is New sbir contract for DHS211-004 sbir phase II crpp on vehicle infectious diseases protection (70RSAT24C00000045), from Office of Procurement Operations, on September 24, 2024.
On GovTribe
See Magplasma, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors